India's drug regulator has significantly accelerated innovation by cutting approval timelines by over 50%. Clinical trial approvals now take 120-135 days, and marketing authorisations are cleared in under 150 days. These structural reforms, including the removal of pre-clinical approval requirements, aim to boost ease of doing business.